東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

TLR4 Signaling Modulates Lipolysis i...

Chirivi, Miguel Leonardo.

Linked to FindBook

Google Book

Amazon

博客來

TLR4 Signaling Modulates Lipolysis in Dairy Cows' Adipose Tissues.

Record Type:	Electronic resources : Monograph/item
Title/Author:	TLR4 Signaling Modulates Lipolysis in Dairy Cows' Adipose Tissues./
Author:	Chirivi, Miguel Leonardo.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2023,
Description:	202 p.
Notes:	Source: Dissertations Abstracts International, Volume: 85-02, Section: B.
Contained By:	Dissertations Abstracts International85-02B.
Subject:	Physiology. -
Online resource:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30575442
ISBN:	9798380113311

TLR4 Signaling Modulates Lipolysis in Dairy Cows' Adipose Tissues.
Chirivi, Miguel Leonardo.

TLR4 Signaling Modulates Lipolysis in Dairy Cows' Adipose Tissues. - Ann Arbor : ProQuest Dissertations & Theses, 2023 - 202 p.

Source: Dissertations Abstracts International, Volume: 85-02, Section: B.

Thesis (Ph.D.)--Michigan State University, 2023.

Excessive lipolysis from adipose tissue (AT) is considered a major risk factor of postpartum metabolic disease in dairy cows. Among those, clinical ketosis occurs when dysregulated lipolysis provides abundant fatty acids for ketone body synthesis. Since excessive and protracted lipolysis increases the risk for disease, limiting lipolysis becomes crucial to mitigate excessive fat mobilization and consequently disease risk. However, the mechanisms behind AT dysregulated lipolysis and how to inhibit it are not fully understood. Additionally, periparturient dairy cows often present inflammatory conditions such as coliform mastitis, metritis, pneumonia, and leaky gut, which result in circulating free endotoxin. Endotoxins, which are the outer component of gram-negative bacteria, can activate TLR4 in cells. Once TLR4 is activated, it leads to various effects including cytokine production, increased metabolic stress, and altered cellular metabolism. However, there is a lack of comprehensive understanding regarding the effects of endotoxins on AT in dairy cows. This work proposes that endotoxin plays a determinant role during the development of metabolic and inflammatory/infectious comorbidities around parturition through the exacerbation of lipolytic responses in AT and reduction of insulin sensitivity. Although some studies have examined the impact of endotoxemia on the metabolism of lipids, the molecular mechanisms underlying the interactions between endotoxins and AT remain poorly characterized. To address this gap, we first studied clinical ketosis, the most representative disease during AT lipolysis dysregulation. We found that cows with clinical ketosis had elevated plasma endotoxin and inflammatory markers. A randomized clinical trial was conducted to investigate the effectiveness of niacin and flunixin as inhibitors of lipolysis during clinical ketosis. Furthermore, given that the physiological role of AT is not fully understood during ketosis, we evaluated the AT function, and we characterize the AT macrophage phenotype involved in CK. We identified that endotoxins and inflammation were playing a determinant role during clinical ketosis and its recovery. Therefore, we developed an ex vivo model of AT inflammation to determine how endotoxins influence lipolytic and inflammatory markers. We found that endotoxin LPS triggers lipolysis and insulin resistance in AT from non-lactating and postpartum dairy cows. Among the pathways involved ERK1/2 was observed as a mediator of activation of lipases HLS and ATGL. To further characterize endotoxin-induced lipolysis, an in vitro cell culture model was developed to assess the mechanisms behind lipolysis in bovine adipocytes exposed to LPS. In our bovine adipocyte inflammation model, endotoxin depends upon the presence of TLR4 to activate lipolysis and inflammation. Adipocytes were also treated with lipolysis inhibitors niacin and flunixin meglumine and then exposed to endotoxin. Flunixin meglumine inhibits lipolysis in adipocytes and improves insulin sensitivity. This work suggests that inflammation is involved in lipolysis dysregulation in dairy cows with clinical ketosis. Our data also provides evidence for the novel therapy for inhibiting lipolysis with faster hyperketonemia recovery, lower lipolytic rates and reduced inflammation. Hence, treating cows with flunixin meglumine reduces inflammation and improves AT function during clinical ketosis. Additionally, our data suggests that TLR4 is mediating lipolysis and inflammation in bovine adipocytes. Therefore, if endotoxins are involved in lipolysis dysregulation, it is important to acknowledge the potential impact of endotoxin on metabolic diseases in dairy cows. Establishing the relationship between low-grade endotoxemia and AT effects, both in the short and long term, should be the focus of future studies. Moreover, future work should be based on further characterizing the mechanisms by which TLR4 activation impacts other adipose tissue functions, such as lipid accumulation.

ISBN: 9798380113311Subjects--Topical Terms:

518431
Physiology.
Subjects--Index Terms:

Adipose tissue

TLR4 Signaling Modulates Lipolysis in Dairy Cows' Adipose Tissues.
LDR:05234nmm a2200421 4500 001 2401104
005 20241015112526.5
006 m o d
007 cr#unu||||||||
008 251215s2023 ||||||||||||||||| ||eng d
020 $a 9798380113311
035 $a (MiAaPQ)AAI30575442
035 $a AAI30575442
035 $a 2401104
040 $a MiAaPQ $c MiAaPQ
100 1 $a Chirivi, Miguel Leonardo. $0 (orcid)0000-0001-6604-2981 $3 3771168
245 1 0 $a TLR4 Signaling Modulates Lipolysis in Dairy Cows' Adipose Tissues.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2023
300 $a 202 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-02, Section: B.
500 $a Advisor: Contreras, Andres.
502 $a Thesis (Ph.D.)--Michigan State University, 2023.
520 $a Excessive lipolysis from adipose tissue (AT) is considered a major risk factor of postpartum metabolic disease in dairy cows. Among those, clinical ketosis occurs when dysregulated lipolysis provides abundant fatty acids for ketone body synthesis. Since excessive and protracted lipolysis increases the risk for disease, limiting lipolysis becomes crucial to mitigate excessive fat mobilization and consequently disease risk. However, the mechanisms behind AT dysregulated lipolysis and how to inhibit it are not fully understood. Additionally, periparturient dairy cows often present inflammatory conditions such as coliform mastitis, metritis, pneumonia, and leaky gut, which result in circulating free endotoxin. Endotoxins, which are the outer component of gram-negative bacteria, can activate TLR4 in cells. Once TLR4 is activated, it leads to various effects including cytokine production, increased metabolic stress, and altered cellular metabolism. However, there is a lack of comprehensive understanding regarding the effects of endotoxins on AT in dairy cows. This work proposes that endotoxin plays a determinant role during the development of metabolic and inflammatory/infectious comorbidities around parturition through the exacerbation of lipolytic responses in AT and reduction of insulin sensitivity. Although some studies have examined the impact of endotoxemia on the metabolism of lipids, the molecular mechanisms underlying the interactions between endotoxins and AT remain poorly characterized. To address this gap, we first studied clinical ketosis, the most representative disease during AT lipolysis dysregulation. We found that cows with clinical ketosis had elevated plasma endotoxin and inflammatory markers. A randomized clinical trial was conducted to investigate the effectiveness of niacin and flunixin as inhibitors of lipolysis during clinical ketosis. Furthermore, given that the physiological role of AT is not fully understood during ketosis, we evaluated the AT function, and we characterize the AT macrophage phenotype involved in CK. We identified that endotoxins and inflammation were playing a determinant role during clinical ketosis and its recovery. Therefore, we developed an ex vivo model of AT inflammation to determine how endotoxins influence lipolytic and inflammatory markers. We found that endotoxin LPS triggers lipolysis and insulin resistance in AT from non-lactating and postpartum dairy cows. Among the pathways involved ERK1/2 was observed as a mediator of activation of lipases HLS and ATGL. To further characterize endotoxin-induced lipolysis, an in vitro cell culture model was developed to assess the mechanisms behind lipolysis in bovine adipocytes exposed to LPS. In our bovine adipocyte inflammation model, endotoxin depends upon the presence of TLR4 to activate lipolysis and inflammation. Adipocytes were also treated with lipolysis inhibitors niacin and flunixin meglumine and then exposed to endotoxin. Flunixin meglumine inhibits lipolysis in adipocytes and improves insulin sensitivity. This work suggests that inflammation is involved in lipolysis dysregulation in dairy cows with clinical ketosis. Our data also provides evidence for the novel therapy for inhibiting lipolysis with faster hyperketonemia recovery, lower lipolytic rates and reduced inflammation. Hence, treating cows with flunixin meglumine reduces inflammation and improves AT function during clinical ketosis. Additionally, our data suggests that TLR4 is mediating lipolysis and inflammation in bovine adipocytes. Therefore, if endotoxins are involved in lipolysis dysregulation, it is important to acknowledge the potential impact of endotoxin on metabolic diseases in dairy cows. Establishing the relationship between low-grade endotoxemia and AT effects, both in the short and long term, should be the focus of future studies. Moreover, future work should be based on further characterizing the mechanisms by which TLR4 activation impacts other adipose tissue functions, such as lipid accumulation.
590 $a School code: 0128.
650 4 $a Physiology. $3 518431
650 4 $a Immunology. $3 611031
650 4 $a Animal sciences. $3 3174829
653 $a Adipose tissue
653 $a Clinical trial
653 $a Dairy cows
653 $a Endotoxin
653 $a Ketosis
653 $a Lipolysis
690 $a 0778
690 $a 0719
690 $a 0982
690 $a 0475
710 2 $a Michigan State University. $b Comparative Medicine and Integrative Biology - Doctor of Philosophy. $3 2093084
773 0 $t Dissertations Abstracts International $g 85-02B.
790 $a 0128
791 $a Ph.D.
792 $a 2023
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30575442